Guselkumab – July 2026

  • Solution for I.V. infusion 200 mg in 20 mL vial
  • Injection 100 mg in 1 mL single use pre-filled pen
  • Injection 200 mg in 2 mL single use pre-filled pen
  • Injection 100 mg in 1 mL single use pre-filled syringe
  • Injection 200 mg in 2 mL single use pre-filled syringe

  • Brand names:
    • Tremfya®
  • Pharmaceutical Company:
    • JANSSEN-CILAG PTY LTD
  • Condition/Indication: Severe Crohn disease (CD)
  • Meeting Date: July 2026

Last updated
13 November 2026